Dr. Lal Path Labs Ltd. — Updates, 31-07-2025: Press Release

Dr Lal PathLabs delivered robust Q1 FY26 consolidated financial results. Revenue grew 11.3% to Rs 670 Cr, reflecting strong business performance. EBITDA increased 13.1% to Rs 192 Cr, maintaining a healthy 28.7% margin. Profit After Tax (PAT) surged 24.3% to Rs 134 Cr, achieving a 20.0% margin. The company also announced an interim dividend of Rs 6 per share for the quarter, signaling solid shareholder returns.